Join the club for FREE to access the whole archive and other member benefits.

Giovanni Traverso

Physician-Scientist, assistant professor at the Massachusetts Institute of Technology (MIT)

C. Giovanni Traverso, MB, BChir, Ph.D. is an Assistant Professor of Medicine at Harvard Medical School and a Gastroenterologist in the Division of Gastroenterology at Brigham and Women’s Hospital. Dr. Traverso completed his Ph.D. thesis on novel technologies for the non-invasive detection of colorectal cancer laboratory of Professor Bert Vogelstein at Johns Hopkins University.

For his post-doctoral research, he transitioned to the fields of chemical and biomedical engineering in the laboratory of Professor Robert Langer at the Massachusetts Institute of Technology (MIT) where he developed a series of novel technologies for drug delivery as well as physiological sensing via the gastrointestinal tract.

His current research program is focused on developing the next generation of drug delivery systems to enable efficient delivery of therapeutics through the gastrointestinal tract. He continues to collaborate closely with Professor Langer and is a Research Affiliate of the Langer Laboratory at MIT.

Visit website:


See also: Academia Massachusetts Institute of Technology (MIT) - Private land-grant research university

Details last updated 03-Oct-2022

Giovanni Traverso News

New vibrating pill tricks your stomach into feeling full

The Guardian - 22-Dec-2023

"Vibes" pill mimics food signals, decreasing food intake by 40% in pigs


Ingestible electronic pill detects sleep apnea and opioid overdoses

New Scientist - 17-Nov-2023

Revolutionary pill that could save lives by alerting for serious medical conditions


Sensor can be tracked through the digestive system to identify blockages

Massachusetts Institute of Technology (MIT) - 13-Feb-2023

Currently only tracking location, but in future could be developed to take samples or deliver therapeutics


Injection-replacement remedy, using a robotic pill to deliver insulin in diabetics

Independent - 30-Sep-2022

RoboCap’s mucus-clearing and churning movements help it deliver the drug directly to the gut